Good Steward Wealth Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
104,503
+30,079
+40% +$366K 0.7% 29
2026
Q1
$1.04M Buy
74,424
+5,113
+7% +$71.7K 0.67% 29
2025
Q4
$997K Buy
69,311
+34,472
+99% +$518K 0.66% 29
2025
Q3
$555K Buy
34,839
+22,944
+193% +$378K 0.38% 32
2025
Q2
$211K Buy
+11,895
New +$232K 0.17% 88

Other funds holding BTAL

Good Steward Wealth Advisors's BTAL Position: Q2 2026 in Review

Good Steward Wealth Advisors increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 40% in Q2 2026, buying an estimated $366K and bringing the position to 104,503 shares worth $1.17M. The position accounts for 0.7% of the portfolio, ranked #29.

Good Steward Wealth Advisors first reported a position in BTAL in Q2 2025 and has held it in 5 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Good Steward Wealth Advisors held 104,503 shares of AGF US Market Neutral Anti-Beta Fund worth $1.17M as of Q2 2026.
  • Good Steward Wealth Advisors bought 30,079 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $366K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.7% of Good Steward Wealth Advisors's portfolio in Q2 2026, its #29 holding.
  • Good Steward Wealth Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2025 and has held it in 5 quarters since.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Good Steward Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.